Novel Water-Soluble Sedative-Hypnotic Agents: Isoindolin-1-one Derivatives
-
- Kanamitsu Norimasa
- Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd.
-
- Osaki Takashi
- Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd.
-
- Itsuji Yutaka
- Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd.
-
- Yoshimura Masakazu
- Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd.
-
- Tsujimoto Hisashi
- Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd.
-
- Soga Manabu
- Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd.
この論文をさがす
抄録
We developed new intravenous sedative-hypnotic compounds with the isoindolin-1-one skeleton focusing on the water-soluble property and in vivo safety. We synthesized approximately 170 derivatives and evaluated their hypnotic effects by intravenous administration of the compounds to mice. A series of the 2-phenyl-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]isoindolin-1-one analogs, 3(−), 5(−), 27(−), and 47(−) [JM-1232(−)], showed potent sedative-hypnotic activity with good water solubility and a wide safety margin. The hypnotic doses (HD50s) of these 4 compounds when administered to mice were 2.35, 1.90, 2.17, and 3.12 mg/kg, respectively, and the lethal doses (LD50s) were 88.67, 64.69, >120, and >120 mg/kg, respectively. The therapeutic indexes (LD50/HD50) were 37.73, 34.05, >55.30, and >38.46, respectively. Among these compound, 47(−) [JM-1232(−)] is being considered as the most potential candidate for clinical trials in humans.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 55 (12), 1682-1688, 2007
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679145365376
-
- NII論文ID
- 110006532108
-
- NII書誌ID
- AA00602100
-
- COI
- 1:CAS:528:DC%2BD1cXht1ymu7g%3D
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 9273849
-
- PubMed
- 18057740
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可